SYDNEY : Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly reduced the growth
Previous Article
EARNINGS... tropeR sgninraE 3Q .proC roulF
Next Article
‘How... ’motA na tilpS ot woH‘